Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 27, 16:00
308.00
-6.35 (-2.02%)
VOLUME 23,229
LIVE
NSE
Mar 27, 15:59
308.25
-6.05 (-1.92%)
VOLUME 200,323
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Stride Arcolab, says Sukhani 

9.40 am | 12 Dec 2011 |  Source: CNBC-TV18

Sudarshan Sukhani, s2analytics.com is of the view that one can buy Stride Arcolab....

Super Six: Top chart picks for today 

8.55 am | 12 Dec 2011 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment, Nooresh Mirani, AMSEC and Vishal B Malkan, CMT,...

Buy Stride Arcolab; target Rs 464: Firstcall Research

2.54 pm | 25 Nov 2011 |  Source: Moneycontrol.com

Firstcall Research is bullish on Stride Arcolab and has recommended buy rating on the stock with a target of Rs 464 in its November 05, 2011 research ...

Strides Arcolab gets two more US FDA nods for cancer drugs

3.45 pm | 24 Nov 2011 |  Source: Moneycontrol.com

Onco Therapies, the unit of pharma company Strides Arcolab, has received US FDA approval for Carboplatin injection 10 mg/ml packaged in pharmacy bulk ...

Bull's Eye: 12 stocks you can bet on Nov 4 

11.55 am | 04 Nov 2011 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Accumulate Stride Arcolab; target of Rs 451: Dolat Capital

2.24 pm | 29 Oct 2011 |  Source: Moneycontrol.com

Dolat Capital is bullish on Stride Arcolab and has recommended accumulate rating on the stock with a target of Rs 451 in its October 25, 2011 research...

Stride Arcolab Sep '11 sales at Rs 196.98 crore

7.45 pm | 25 Oct 2011 |  Source: Moneycontrol.com

Stride Arcolab has reported a sales turnover of Rs 196.98 crore and a net loss of Rs 65.19 crore for the quarter ended Sep '11...

Yes Bank, Lanco, ABG Shipyard good picks: Anantakrishnan 

6.05 pm | 20 Oct 2011 |  Source: CNBC-TV18

Yes Bank, Lanco and ABG Shipyard are good picks, says TS Anantakrishnan, Director, Prime Broking....

Strides Arcolab gets USFDA nod for general anaesthetic

10.08 am | 20 Oct 2011 |  Source: Moneycontrol.com

Pharma company Strides Arcolab has received two advanced new drug approvals (ANDA) from US Food and Drugs Administration (FDA) for general anaesthetic...

Stride Arcolab has target of Rs 352: Aashish Tater 

2.34 pm | 11 Oct 2011 |  Source: CNBC-TV18

Stride Arcolab has target of Rs 352, says Aashish Tater of Fort Share Broking....

Bull's Eye: Buy Pipavav, VIP, Gitanjali Gema; short Sun TV 

11.12 am | 11 Oct 2011 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Strides Arcolab gets US FDA nod for antibacterial injection

2.35 pm | 03 Oct 2011 |  Source: Moneycontrol.com

Pharma company Strides Arcolab has received approval from US Food and Drugs Administration (FDA) for Clindamycin injection, an antibiotic used to trea...

Strides Arcolab gets US FDA nod for cancer treatment drugs

11.01 am | 30 Sep 2011 |  Source: Moneycontrol.com

Pharma company Strides Arcolabs unit Onco Therapies has received US Food and Drugs Administration (FDA) approval for Paclitaxel injection used to tre...

Buy Stride Arcolab, says Sharmila Joshi 

12.46 pm | 23 Sep 2011 |  Source: CNBC-TV18

Buy Stride Arcolab, says Sharmila Joshi of Fairwealth Securities....

Bull's Eye: Short Sesa Goa, Educomp, Sterlite Ind; buy Eros 

11.10 am | 23 Sep 2011 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Book profit in Stride Arcolab: Ashish Chaturmohta 

1.09 pm | 22 Sep 2011 |  Source: Moneycontrol.com

Book profit in Stride Arcolab, says Ashish Chaturmohta of IIFL Wealth. ...

Strides' Bangalore plant gets USFDA approval

5.43 pm | 14 Sep 2011 |  Source: PTI

Drug firm Strides Arcolab today said the US health regulator has extended its approval for the company's facility at Bangalore....

Stride Arcolab Jun '11 sales at Rs 200.93 crore

4.17 pm | 29 Jul 2011 |  Source: Moneycontrol.com

Stride Arcolab has reported a sales turnover of Rs 200.93 crore and a net profit of Rs 14.61 crore for the quarter ended Jun '11...

Stride Arcolab has target of Rs 475: PN Vijay 

9.34 am | 29 Jul 2011 |  Source: CNBC-TV18

Stride Arcolab has target of Rs 475, says PN Vijay, Portfolio Manager. ...

Strides Arcolab gets USFDA nod for anti-diabetic drug

4.35 pm | 28 Jul 2011 |  Source: PTI

Drug firm Strides Arcolab today said it has received the US health regulator's nod to market Acarbose tablets, an anti-diabetic drug, in the American ...

1 2 3
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.